Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas
1988

Ki-67 Reactivity in Breast Carcinomas

Sample size: 95 publication Evidence: moderate

Author Information

Author(s): R.A. Walker, R.S. Camplejohn

Hypothesis

The study aims to assess the value of Ki-67 in estimating the proliferative activity of breast carcinomas by comparing its reactivity with histological grade and S-phase fraction determined by DNA flow cytometry.

Conclusion

The presence of nuclear staining with Ki-67 is significantly associated with poorer histological grade and higher S-phase content in breast carcinomas.

Supporting Evidence

  • 56% of breast carcinomas showed evidence of nuclear staining with Ki-67.
  • There was a significant correlation between nuclear staining and poorer histological grade.
  • 78% of poorly differentiated carcinomas exhibited nuclear staining.
  • 47% of tumours with moderate S-phase content showed nuclear reactivity.

Takeaway

This study looked at how a special marker called Ki-67 can help doctors understand how fast breast cancer cells are growing, which can help predict how serious the cancer might be.

Methodology

The study involved assessing Ki-67 reactivity in 95 breast carcinoma samples and comparing it with histological grade and S-phase content determined by DNA flow cytometry.

Limitations

The study does not provide sufficient clinical follow-up data to determine the prognostic value of Ki-67 reactivity.

Statistical Information

P-Value

0.05>P>0.02

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication